MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Corcept Therapeutics Incorporated Historical Prices 2011-2026 | CORT
Annual Historical Prices Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.4 | 24.6 | 20.9 | 19.8 | 26.2 | 12.1 | 13.4 | 18.1 | 7.26 | 4.98 | 3 | 3.21 | 1.43 | 3.42 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.4 | 1.43 | 15.8 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
27 | $ 28.91 | 4.94 % | $ 1.4 B |  USA |
 |
Amarin Corporation plc
AMRN
|
1.08 | $ 15.03 | 1.14 % | $ 6.13 B |  Irlanda |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M |  Canada |
 |
argenx SE
ARGX
|
615 | $ 836.13 | 0.31 % | $ 25 B |  Niderland |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
3.41 | $ 4.14 | 5.61 % | $ 353 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Adagene
ADAG
|
1.56 | $ 3.18 | 11.58 % | $ 179 M | China |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.78 | -8.44 % | $ 4.25 M | China |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Biogen
BIIB
|
201 | $ 198.18 | 1.37 % | $ 29 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.47 | -1.12 % | $ 8.35 B |  Australia |
 |
Bristol-Myers Squibb Company
BMY
|
60.2 | $ 60.84 | 1.64 % | $ 124 B | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 106.92 | 1.1 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 217.6 | -0.23 % | $ 5 B |  Danmark |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |
 |
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
48.8 | $ 53.56 | 9.46 % | $ 4.82 B |  Schweiz |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.41 | 2.32 % | $ 360 M | Britain |
 |
Burford Capital Limited
BUR
|
10.6 | $ 9.35 | 0.54 % | $ 1.51 B | Britain |
 |
Amneal Pharmaceuticals
AMRX
|
5.91 | $ 14.93 | 2.02 % | $ 4.61 B | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |